Terraplasma Medical GmbH specializes in the development and application of cold plasma technology for medical use, particularly in the treatment of chronic and acute wounds. The company operates in the healthcare sector, serving hospitals, clinics, and healthcare providers who require advanced solutions for wound care. Terraplasma Medical's core product line includes mobile devices that utilize cold plasma to inactivate bacteria, viruses, fungi, and spores, while simultaneously promoting the healing process by activating healthy cell proliferation. This dual-action approach not only enhances the effectiveness of wound treatment but also reduces the risk of resistance and allergies, making it a valuable tool in modern medicine.

The company generates revenue through the sale of its plasma devices and related consumables, as well as through partnerships and collaborations with healthcare institutions and research organizations. By focusing on innovative technology and evidence-based results, Terraplasma Medical aims to improve patient outcomes and set new standards in wound care.

Keywords: cold plasma, wound treatment, pathogen inactivation, healing promotion, healthcare technology, chronic wounds, acute wounds, medical devices, resistance-free, cell proliferation.